Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Simultaneous Quantification of Naproxen and Esomeprazole in Pharmaceutical Formulations by Reversed-Phase Chromatography (RP-HPLC/RP-UPLC) (CAT#: STEM-CT-2456-CJ)

Introduction

Naproxen (NPX) is chemically known as (+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acid, which is used as a nonsteroidal anti-inflammatory drug (NSAID). It is commonly used for relief of a wide variety of pain, fever, inflammations and stiffness arises from various physiological disorders such as osteoarthritis, rheumatoid arthritis, psoriatic arthritis, migraine, gout, kidney stones, menstrual cramps, tendinitis, bursitis, etc. NPX has potential capability of causing ulcers and stomach bleeding just like other nonselective COX2 inhibitors. Therefore, it is pharmacologically rational to give any acid-suppressing agent concurrently with NPX. Traditionally, proton pump inhibitors (PPIs) have become a drug of choice in this case. Among several PPIs, esomeprazole (ESP), the S-isomer of omeprazole, is extensively used during treatment with NPX due to the fact that ESP provides more effective acid control than omeprazole, with reduced interpatient variability, thereby offering the potential for improved efficacy in acid-related diseases.




Principle

Reversed-phase chromatography is a technique using hydrophobic molecules covalently bonded to the stationary phase particles in order to create a hydrophobic stationary phase, which has a stronger affinity for hydrophobic or less polar compounds. The use of a hydrophobic stationary phase is essentially the reverse of normal phase chromatography, since the polarity of the mobile and stationary phases have been inverted – hence the term reversed-phase chromatography. Reversed-phase chromatography employs a polar (aqueous) mobile phase. As a result, hydrophobic molecules in the polar mobile phase tend to adsorb to the hydrophobic stationary phase, and hydrophilic molecules in the mobile phase will pass through the column and are eluted first. Hydrophobic molecules can be eluted from the column by decreasing the polarity of the mobile phase using an organic (non-polar) solvent, which reduces hydrophobic interactions. The more hydrophobic the molecule, the more strongly it will bind to the stationary phase, and the higher the concentration of organic solvent that will be required to elute the molecule.

Applications

Biopharmaceuticals; Biomedical; Pharmaceuticals

Procedure

1. Sample preparation.
2. Select the appropriate HPLC/UHPLC columns.
3. Set the operating conditions of the instrument and run the equipment.
4. Collect and analyse data.

Materials

• Sample: Blood; Urine; Plasma; Tissues; Drugs; Proteins; Peptides; Nucleic acids; Nucleotides & More.
• Equipment: HPLC machine; Reversed phase HPLC/UHPLC columns; HPLC/UHPLC systems.
• (Optional) Chromatographic solvents; Eppendorf vials; HPLC autosampler vials; Hypercarb Porous Graphitic Carbon HPLC Columns.

Notes

1. Reversed-phase chromatography is a commonly used, high-throughput analytical technique that allows the separation of analytes based on differences in hydrophobicity.
2. The reverse phase HPLC uses a nonpolar stationary phase and a polar mobile phase whereas the normal phase HPLC uses a polar stationary phase and a less polar mobile phase.
3. Reversed phase high performance liquid chromatography has been used successfully in the analysis and purification of polypeptides, small polypeptides and drugs.
Advertisement